Comparison of the association between COVID-19 and new onset diabetes in a regional and national dataset [0.03%]
基于区域和国家数据集对COVID-19与新发糖尿病之间关系的比较研究
Mary E Lacy,Aaron P Smith,Lindsey R Hammerslag et al.
Mary E Lacy et al.
Aims: This study examined new onset diabetes following COVID-19 infection in large datasets. Methods: A retrospective cohort study desi...
Triglycerides to high density lipoprotein cholesterol ratio (TG/HDL), but not triglycerides and glucose product (TyG) index, is associated with arterial stiffness in prediabetes [0.03%]
在糖尿病前期患者中，甘油三酯与高密度脂蛋白胆固醇比值(TG/HDL)，而非甘油三酯和血糖积指数(TyG)与动脉僵硬度相关
Maurizio Di Marco,Sabrina Scilletta,Nicoletta Miano et al.
Maurizio Di Marco et al.
Aims: Prediabetes (preD) carries increased risk of cardiovascular (CV) events than normal-glucose-tolerance (NGT). Insulin resistance, a hallmark of preD, is closely linked to CV-risk, making its assessment crucial. Trigl...
Non-adherence to diabetes microvascular complications follow-up screening in the primary care population: Predictors, associated barriers, and facilitators [0.03%]
基层糖尿病患者微量白蛋白尿筛查依从性及其影响因素和促进因素研究
Eva K Fenwick,Amudha Aravindhan,Ngiap Chuan Tan et al.
Eva K Fenwick et al.
Aims: We determined the rates, predictors, and barriers/facilitators of non-adherence to annual follow-up screenings for Diabetic Retinopathy (DR), nephropathy (DN) and foot complications (DFC) screening in primary care p...
The impact of sex-related disparities on the association between triglyceride-glucose index and renal function decline in patients with type 2 diabetes: Insights from the ACCORD trial [0.03%]
性别差异对II型糖尿病患者三酰甘油-葡萄糖指数与肾功能下降关联影响的横断面研究——来自ACCORD试验的启示
Xiaopu Wang,Keyang Zheng,Xinqun Hu et al.
Xiaopu Wang et al.
Background: The triglyceride-glucose (TyG) index has emerged as a surrogate marker for insulin resistance and is associated with the incidence and progression of chronic kidney disease (CKD) in patients with type 2 diabet...
The burden of type 2 diabetes in China from 1990 to 2021: A comparative analysis with G20 countries using the global burden of disease study 2021 [0.03%]
中国糖尿病负担（1990年-2021年）：利用全球疾病负担研究（2021）与G20国家进行比较分析
Kang An,Jinyi Zhang,Xingyou Wang et al.
Kang An et al.
Objectives: The study aims to evaluate the burden of Type 2 Diabetes (T2D) in China from 1990 to 2021, and compare to it across G20 countries. Methods: ...
Making Sense: Feasibility of an education program to Empower adults with type 1 diabetes to interpret CGM data [0.03%]
解读CGM数据成人教育项目的可行性研究——“使能计划”
Georgina Manos,John Apostolopoulos,Meaghan Read et al.
Georgina Manos et al.
Aims: To assess the feasibility and acceptability of a structured education program focused on continuous glucose monitoring (CGM) data interpretation for adults living with type 1 diabetes. ...
Neurovascular decoupling of frontoparietal cortex-putamen-cerebellum network in type 2 diabetes patient: Potential biomarker for abnormal eating patterns [0.03%]
2型糖尿病患者的前顶叶皮层-壳核-小脑网络的神经血管脱偶联：异常饮食模式的潜在生物标志物
Ying Yu,Bo Hu,Xin-Wen Yu et al.
Ying Yu et al.
Aim: High rates of dropout and binge eating triggered by restrictive diet limit the effectiveness of dietary interventions in type 2 diabetes mellitus (T2DM). However, it remains unclear the potential central underpinning...
Sodium-Glucose Cotransporter2 inhibitors and associated Liver-Related outcomes in diabetes patients [0.03%]
钠葡萄糖共转运蛋白2抑制剂与糖尿病患者的肝脏相关结局
Fu-Shun Yen,James Cheng-Chung Wei,Chen Wang et al.
Fu-Shun Yen et al.
Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with poorer liver-related outcomes in type 2 diabetes (T2D) patients. We compared risk of liver-related outcomes and all-cause mortality...
Persistence with once-weekly glucagon-like peptide 1 receptor agonist therapy decreases the risk of major adverse cardiovascular events: A retrospective analysis of patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease [0.03%]
每周一次的胰高血糖素样肽-1受体激动剂治疗的持续性可降低2型糖尿病合并动脉粥样硬化性心血管疾病患者的不良心血管事件风险：一项回顾性分析研究
Tyler J Dunn,Yong Zhu,Noelle N Gronroos et al.
Tyler J Dunn et al.
Aims: To assess the association between remaining persistent with once-weekly glucagon-like peptide-1 receptor agonists (OW GLP-1 RAs) and the risk of major adverse cardiovascular events (MACE) among patients with type 2 ...